[Experiences with the cytostatic agent tris-ethyleneiminobenzoquinone (Trenimon) in children].
D000970:Antineoplastic Agents; D054697:Cytostatic Agents; D006390:Hemangioendothelioma; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D007951:Leukemia, Myeloid; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009369:Neoplasms; D012516:Osteosarcoma; D012509:Sarcoma
D000970:Antineoplastic Agents; D054697:Cytostatic Agents
ANTINEOPLASTIC AGENTS; HEMANGIOENDOTHELIOMA; HODGKIN'S DISEASE; LEUCOSARCOMA; LEUKEMIA, MYELOCYTIC; SARCOMA, OSTEOGENIC; SARCOMA, RETICULUM CELL